Atlas Trials

Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects

Clinical trial NCT03424733 · UNKNOWN

Trial details

NCT number
NCT03424733
Sponsor
Holy Name Medical Center, Inc.
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2017-09-25
Primary completion
2020-05-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.